GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
CDC Says Childhood Diabetes Could Increase Nearly 700% By 2060
2023-01-03
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
Acer Snags First-Ever FDA Approval With Relief-Partnered Olpruva
2022-12-28
Roche’s Lunsumio Lands FDA Approval for Pretreated Follicular Lymphoma
2022-12-26
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
Entrada Hit With Clinical Hold on IND Application for Muscular Dystrophy Therapy
2022-12-20
GSK Buys into Wave’s Oligonucleotide Program With $170 Million
2022-12-14
Clovis Offloads Cancer Candidate to Novartis, Day After Declaring Bankruptcy
2022-12-13
Amgen Leads the Pack After Sanofi Drops Out of Horizon Bid
2022-12-11
Relmada Blames ‘Implausible Placebo Results’ on Depression Drug’s Failure Again
2022-12-07
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
1 2 3 4 5 6 15
Scroll to Top